BIOTEST AG

Company Overview

Biotest AG specializes in critical care medicine, clinical immunology, and innovative hematology.
Biotest creates, produces, and sells biotherapeutic medications and plasma proteins. From pre-clinical and clinical development to global marketing and distribution, their value chain is extensive. Biotests use human blood plasma to produce immunoglobulins, clotting factors, and albumins. Apart from its corporate headquarters located in Dreieich, close to Frankfurt, Germany, Biotest also maintains subsidiaries in Austria, Switzerland, Hungary, and the Czech Republic. Currently, the company’s products are sold in over 70 countries worldwide. Biotest either works with regional distributors or marketing partners, or it sells its goods directly through its subsidiaries.

Financial Highlights (FY 2024)

Company's Business Segments

• Products : Haemoctin SDH, Haemonine, Yimmugo, Cytotect CP, Hepatect CP, Varitect, Albiomin, Biseko, Pentaglobin, Others
• Services : Technology disclosure and Development services